Abstract
Nigel S B Rawson, PhD, Canadian Health Policy Institute ABSTRACT Canada has experienced much uncertainty about the federal government’s intention to regulate lower ceiling prices for patented medicines during the past seven years. This study’s objective was
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have